✦ LIBER ✦
Safety and efficacy of only 2 weeks of ticlopidine therapy in patients at increased risk of coronary stent thrombosis: Results from the Antiplatelet Therapy alone versus Lovenox plus Antiplatelet therapy in patients at increased risk of Stent Thrombosis (ATLAST) trial
✍ Scribed by Peter B. Berger; Ken W. Mahaffey; Susan J. Meier; Christopher E. Buller; Wayne Batchelor; Edward T.A. Fry; James P. Zidar
- Book ID
- 117842788
- Publisher
- Elsevier Science
- Year
- 2002
- Tongue
- English
- Weight
- 96 KB
- Volume
- 143
- Category
- Article
- ISSN
- 1097-6744
No coin nor oath required. For personal study only.